AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
This is getting the accelerated approval chances a... See more
Jan, 28, 2023
$AVXL Kun Jin hire is the best indication we'r... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call ... See more
Feb, 4, 2023
$TGTX Good TG week, nice to see the trend continue... See more
KALA
Kala Pharmaceuticals Inc
-9.01%
$16.65 - $15.15
Feb 7th 2023 - Mar 21st 2023
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where ... See more
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
Feb, 4, 2023
This is getting the accelerated approval chances as clost to 100% as you humanly can.
Jan, 28, 2023
$AVXL Kun Jin hire is the best indication we're going full bore for alz approval ASAP.
Jan, 24, 2023
He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.
Jan, 13, 2023
Anavex can still rise .. Blarcamesine will likely get approval around the world 🌎
Jan, 12, 2023
So the current price level is so cheap and has so little downside that even with concerns about data and approval, the stock can rise 5x from here.
Jan, 6, 2023
That's all perfect it's everything needed for full approval!
Jan, 6, 2023
Well it was bound for an approval because the bar is low and aggregate economic benefit would far outweigh the aggregate economic burden from funerals cost Bullish for $AVXL $BIVI
Jan, 6, 2023
look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
I think this bodes well for A2-73 getting AA and approval, being it is much safer and with better efficacy, it appears AA is coming to A2-73,
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!
Feb, 4, 2023
$TGTX Good TG week, nice to see the trend continue since approval. 😎🙏😎
Jan, 21, 2023
They're FDA approved, have the best in class treatment, and is more affordable than the others.
Jan, 11, 2023
Best drug approval of 2022.
Jan, 6, 2023
Freshly approved drug and undervalued would mean the JP conference should be ideal for us.
Jan, 4, 2023
$AUPH regardless of where the market goes 2023 will be a very good year for $AUPH and $TGTX Both having best in class block buster potential drugs approved
Dec, 30, 2022
$TGTX successfully on time launch in Q1 2023 and EU approval mid year, we will be back to highs.
Dec, 30, 2022
$TGTX is up 13% continued momentum following MS drug approvals.
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
Dec, 28, 2022
$KALA FDA approved!
Dec, 28, 2022
Successful development and potential approval for KPI-012 will be a huge boost for the company.